CVE:NXG

NexgenRx Stock Forecast, Price & News

C$0.34
-0.01 (-1.45 %)
(As of 09/15/2021 10:38 AM ET)
Add
Compare
Today's Range
C$0.34
C$0.35
50-Day Range
C$0.33
C$0.45
52-Week Range
C$0.14
C$0.60
Volume225,000 shs
Average Volume32,932 shs
Market CapitalizationC$23.91 million
P/E Ratio12.14
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NXG News and Ratings via Email

Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter.


About NexgenRx

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.41 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











NexgenRx (CVE:NXG) Frequently Asked Questions

What stocks does MarketBeat like better than NexgenRx?

Wall Street analysts have given NexgenRx a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NexgenRx wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is NexgenRx's next earnings date?

NexgenRx is scheduled to release its next quarterly earnings announcement on Thursday, November 18th 2021.
View our earnings forecast for NexgenRx
.

How has NexgenRx's stock price been impacted by Coronavirus (COVID-19)?

NexgenRx's stock was trading at C$0.18 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NXG stock has increased by 88.9% and is now trading at C$0.34.
View which stocks have been most impacted by COVID-19
.

Who are NexgenRx's key executives?

NexgenRx's management team includes the following people:
  • Mr. Ronald C. Loucks, Founder, CEO, Pres & Director (Age 71, Pay $152.58k)
  • Mr. Kelly Ehler CPA, CA, Chief Financial Officer
  • Mr. Hugh C. Hart, VP of Sales & Account Management
  • Mr. Andrew Munroe, Director of Operations
  • Ms. Margaret Ingram, Pharmacist Consultant

Who are some of NexgenRx's key competitors?

What other stocks do shareholders of NexgenRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NexgenRx investors own include WestJet Airlines (WJA) and Hydro One (H).

What is NexgenRx's stock symbol?

NexgenRx trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NXG."

How do I buy shares of NexgenRx?

Shares of NXG and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is NexgenRx's stock price today?

One share of NXG stock can currently be purchased for approximately C$0.34.

How much money does NexgenRx make?

NexgenRx has a market capitalization of C$23.91 million and generates C$10.86 million in revenue each year.

What is NexgenRx's official website?

The official website for NexgenRx is www.nexgenrx.com.

Where are NexgenRx's headquarters?

NexgenRx is headquartered at 185 the West Mall Suite 600, ETOBICOKE, ON M9C 5L5, Canada.

How can I contact NexgenRx?

NexgenRx's mailing address is 185 the West Mall Suite 600, ETOBICOKE, ON M9C 5L5, Canada. The company can be reached via phone at +1-416-6953393.


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.